147 related articles for article (PubMed ID: 19446500)
1. Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy.
Grimard L; Esche B; Lamothe A; Spaans JN
Brachytherapy; 2009; 8(3):284-9. PubMed ID: 19446500
[TBL] [Abstract][Full Text] [Related]
2. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies.
Grimard L; Esche B; Lamothe A; Cygler J; Spaans J
Head Neck; 2006 Oct; 28(10):888-95. PubMed ID: 16721742
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
[TBL] [Abstract][Full Text] [Related]
5. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
[TBL] [Abstract][Full Text] [Related]
6. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers.
Kupferman ME; Morrison WH; Santillan AA; Roberts D; Diaz EM; Garden AS; Weber R
Cancer; 2007 May; 109(10):2052-7. PubMed ID: 17407106
[TBL] [Abstract][Full Text] [Related]
7. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.
Martínez-Monge R; Alcalde J; Concejo C; Cambeiro M; Garrán C
Brachytherapy; 2006; 5(1):32-40. PubMed ID: 16563995
[TBL] [Abstract][Full Text] [Related]
8. High-dose-rate brachytherapy plus neck dissection for nodal disease.
Beitler JJ; Garg M; Owen RP; Sarta C; Yaparpalvi R; Smith RV
Head Neck; 2008 Jul; 30(7):933-8. PubMed ID: 18327781
[TBL] [Abstract][Full Text] [Related]
9. Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients.
Le Scodan R; Pommier P; Ardiet JM; Montbarbon X; Malet C; Favrel V; Zrounba P; Poupart M; Céruse P; Ferlay C; Clippe S
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):441-8. PubMed ID: 16168837
[TBL] [Abstract][Full Text] [Related]
10. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative single fraction high-dose-rate brachytherapy for head and neck cancers.
Nag S; Koc M; Schuller DE; Tippin D; Grecula JC
Brachytherapy; 2005; 4(3):217-23. PubMed ID: 16182222
[TBL] [Abstract][Full Text] [Related]
12. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
13. Preliminary report of pulsed dose rate brachytherapy in head-and-neck cancer.
Ziemlewski A; Zienkiewicz J; Serkies K; Badzio A
Strahlenther Onkol; 2007 Sep; 183(9):512-6. PubMed ID: 17762926
[TBL] [Abstract][Full Text] [Related]
14. Role of interstitial PDR brachytherapy in the treatment of oral and oropharyngeal cancer. A single-institute experience of 236 patients.
Strnad V; Melzner W; Geiger M; Zenk J; Waldfahrer F; Lotter M; Ott O; Seeger A; Iro H; Sauer R
Strahlenther Onkol; 2005 Dec; 181(12):762-7. PubMed ID: 16362785
[TBL] [Abstract][Full Text] [Related]
15. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?
Melzner WJ; Lotter M; Sauer R; Strnad V
Radiother Oncol; 2007 Feb; 82(2):167-73. PubMed ID: 17258340
[TBL] [Abstract][Full Text] [Related]
16. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
[TBL] [Abstract][Full Text] [Related]
17. Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung.
Trombetta MG; Colonias A; Makishi D; Keenan R; Werts ED; Landreneau R; Parda DS
Brachytherapy; 2008; 7(1):50-4. PubMed ID: 18299113
[TBL] [Abstract][Full Text] [Related]
18. Role and extent of neck dissection for persistent nodal disease following chemo-radiotherapy for locally advanced head and neck cancer: how much is enough?
Sandhu A; Rao N; Giri S; He F; Karakla D; Wadsworth T; McGaughey D; Silverberg M
Acta Oncol; 2008; 47(5):948-53. PubMed ID: 17906982
[TBL] [Abstract][Full Text] [Related]
19. Paraganglioma of the head and neck: long-term local control with radiotherapy.
Chino JP; Sampson JH; Tucci DL; Brizel DM; Kirkpatrick JP
Am J Clin Oncol; 2009 Jun; 32(3):304-7. PubMed ID: 19433962
[TBL] [Abstract][Full Text] [Related]
20. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: treatment techniques and results.
Maalej M; Ben Ammar CN; Kochbati L; Frikha H; Hentati D; Gargouri W; Besbes M
Cancer Radiother; 2007 May; 11(3):117-21. PubMed ID: 17293150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
